Antimalarial Research Compound Overview
HCQS 400 mg manufactured by Ipca Laboratories is a hydroxychloroquine sulfate formulation representing a 4-aminoquinoline antimalarial compound widely studied in pharmaceutical research. This chloroquine derivative demonstrates established mechanisms of action through interference with parasitic heme detoxification pathways and lysosomal pH modulation in laboratory investigations. Research teams examining antimalarial pharmacology and autoimmune pathways frequently evaluate this compound’s molecular interactions with cellular processes. Studies conducted by Stroid UK Shop have established hydroxychloroquine as a critical reference standard for comparative antimalarial efficacy assessments.
Laboratory Investigation Applications
Research applications for HCQS encompass malaria parasite lifecycle studies, examining the compound’s interference with hemoglobin digestion within Plasmodium falciparum food vacuoles. Scientists investigating autoimmune disease mechanisms analyse hydroxychloroquine’s immunomodulatory properties through Toll-like receptor inhibition and cytokine production suppression. Pharmaceutical researchers studying dermatological applications examine this compound’s effects on inflammatory cascades and photosensitivity reactions. Laboratory protocols frequently incorporate HCQS for investigating drug resistance mechanisms and combination therapy synergistic effects with other antimalarial agents.
Research Compound Specifications
| Property | Specification |
|---|---|
| Active Ingredient | Hydroxychloroquine Sulfate |
| Strength | 400 mg per tablet |
| Manufacturer | Ipca Laboratories Ltd |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Conditions | Room temperature, dry environment |
Quality assurance protocols ensure consistent pharmaceutical-grade material suitable for rigorous laboratory investigations. Research teams studying selective modulators and bioactive peptides often require reliable antimalarial reference compounds for comparative pharmacological studies.
Research Use Compliance
This product is manufactured by Ipca Laboratories exclusively for in-vitro laboratory research purposes. Not intended for human consumption, therapeutic use, or clinical applications. Research institutions and qualified laboratories should ensure proper handling protocols and regulatory compliance within their jurisdictions when conducting studies with this antimalarial compound.
